Skip to the content
ClearNote Health logologo darklogo light
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
Search
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
HomeEvent(Page 2)
Event

9th Liquid Biopsy for Precision Oncology Summit | February 18-20

cnhnewcorpdev
February 18, 2025
Event

Society for Immunotherapy of Cancer | Nov 6 – 10, 2024

cnhnewcorpdev
October 8, 2024
Event

AACR Special Conference on Liquid Biopsy | November 12 -16, 2024

cnhnewcorpdev
October 7, 2024
Event

CGA-IGC – Hereditary Gastrointestinal Cancer | Nov 14-16, 2024

cnhnewcorpdev
October 6, 2024
Event

ISPOR Europe | Nov 17-20, 2024

cnhnewcorpdev
October 5, 2024
Event

14th World CB & CDx Boston Summit | September 3rd – 6th, 2024

cnhnewcorpdev
August 6, 2024
Event

American Diabetes Association 84th Scientific Sessions | June 21st – 24th, 2024

cnhnewcorpdev
June 2, 2024
Event

American Society of Clinical Oncology (ASCO) | May 31st – June 4th, 2024

cnhnewcorpdev
June 1, 2024
Event

Digestive Disease Week | May 18th – 21st, 2024

cnhnewcorpdev
May 2, 2024
Event

American Medical Association CPT Editorial Panel Meeting | May 9th – 11th, 2024

cnhnewcorpdev
May 1, 2024

Posts pagination

1 2 3 4

Meet Us at ASCO 2026

ClearNote Health
May 28, 2026

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

ClearNote Health
May 27, 2026

Follow us
ClearNote Health logo

Empowering early cancer detection.

Order Test
Company
  • About Us
  • Leadership Team
  • Our News
  • Careers
  • Contact Us
Solutions
  • Avantect Pancreatic Cancer Test
  • Avantect Ovarian Cancer Test
  • Virtuoso Epigenomics Platform
Stay Informed

Get the latest research and announcements from ClearNote Health. Follow us:

Important information: 
The Virtuoso platform is for research use only. Not for use in diagnostic procedures. The Avantect Pancreatic and Ovarian Cancers Tests are early detection tests. The tests do not establish a diagnosis of pancreatic cancer or ovarian cancer, respectively, and results should be considered in the context of other clinical criteria.

Cancer statistics quoted on this website are taken from the CDC and SEER websites, 2025 data.

©2026 ClearNote Health, All Rights Reserved.

Avantect and Virtuoso are trademarks of ClearNote Health. Other trademarks are the property of their respective owners.

  • Privacy Policy
  • Terms of Use
  • Billing rights & protections
  • Cookie Preferences